Articles From: AmerisourceBergen to Acquire MWI Veterinary Supply, the Leading Animal Health Distribution Company in the United States to Amgen Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts


2015/1/12
AmerisourceBergen (NYSE:ABC) and MWI Veterinary Supply, Inc. (NASDAQ:MWIV) today announced that they have entered into a definitive merger agreement for AmerisourceBergen to acquire MWI Veterinary Supply (MWI), the leading animal health distribution company in the United States.
Sign-up for AmerisourceBergen to Acquire MWI Veterinary Supply, the Leading Animal Health Distribution Company in the United States investment picks
2015/1/28
Amerita, Inc., a wholly owned subsidiary of PharMerica Corporation (NYSE:PMC), today announced that it has completed the acquisition of Coastal Pharmaceutical Services Corporation, d/b/a InfusionRx (“InfusionRx”). Financial terms of the transaction were not disclosed.
Sign-up for Amerita, a Subsidiary of PharMerica, Accelerates Growth with the Acquisition of InfusionRx investment picks
2015/1/20
Airborne Maintenance & Engineering Services (AMES) completed its first Split-Scimitar Winglet installation for Sunwing Airlines on a B737-800 aircraft.
Sign-up for AMES Completes Split-Scimitar Winglet Modification for Canadian Operator Sunwing Airlines investment picks
2015/2/23
Airborne Maintenance and Engineering Services, Inc. (AMES) announced that it has been granted a Class 4 Airframe Rating by the U.S. Federal Aviation Administration (FAA). This rating gives AMES broad approval to perform maintenance on nearly all commercial aircraft that can be accommodated within its hangar facilities.
Sign-up for AMES Granted Class 4 Airframe Rating By FAA investment picks
2015/1/7
Earnings to be Released before the Market Opens on Wednesday, January 28, 2015 Webcast Scheduled for 8:30 AM ET on Wednesday, January 28, 2015 BERWYN, Pa.
Sign-up for AMETEK Announces Fourth Quarter 2014 Earnings Release and Webcasted Investor Conference Call investment picks
2015/1/28
-- Fourth Quarter Adjusted Earnings per Share up 15% -- BERWYN, Pa.
Sign-up for AMETEK Announces Record Fourth Quarter 2014 Results investment picks
2015/2/5
BERWYN, Pa.
Sign-up for AMETEK Declares Quarterly Dividend Of Nine Cents Per Share investment picks
2015/2/13
By Trey Williams, MarketWatch NEW YORK (MarketWatch)--American Express Co.'s decision to part ways with Costco Wholesale is one that comes as both bad news and good news, analysts said Friday That assessment comes a day after American Express (AXP) announced the end of its exclusive partnership with Costco, and subsequently suffered its largest one-day price drop since September 2008.
Sign-up for Amex in good position despite losing Costco deal investment picks
2015/2/12
American Express Company (AXP) said Thursday it will end its U.S. co-branding and merchant acceptance agreement with Costco Wholesale Corp.
Sign-up for Amex, Costco to end partnership March 31, 2016 investment picks
2015/2/13
By Robin Sidel American Express Co.
Sign-up for AmEx, JetBlue End Co-Branded Credit Card -- Update investment picks
2015/2/13
By Robin Sidel American Express Co.
Sign-up for AmEx, JetBlue End Co-Branded Credit-Card Deal investment picks
2014/12/26
Affiliated Managers Group, Inc. (NYSE: AMG) today announced the completion of its additional investment in AQR Capital Management, LLC, a leading global investment manager.
Sign-up for AMG Completes Investment in AQR Capital Management investment picks
2014/12/17
Affiliated Managers Group, Inc. (NYSE: AMG) today announced it has agreed to a transaction which will result in a meaningful increase in its minority investment in AQR Capital Management, LLC, a leading global investment manager and an AMG Affiliate since 2004.
Sign-up for AMG Increases its Investment in AQR Capital Management investment picks
2015/1/27
Affiliated Managers Group, Inc. (NYSE: AMG) today reported its financial and operating results for the fourth quarter and full year 2014.
Sign-up for AMG Reports Financial and Operating Results for the Fourth Quarter and Full Year 2014 investment picks
2015/1/20
Affiliated Managers Group, Inc. (NYSE: AMG) will report financial and operating results for the fourth quarter and full year ended December 31, 2014 on Tuesday, January 27, 2015.
Sign-up for AMG to Announce Fourth Quarter and Full Year Results on January 27, 2015 investment picks
2015/1/27
AMG Wealth Partners, LP, a subsidiary of Affiliated Managers Group, Inc. (NYSE: AMG), has entered into a definitive agreement to acquire a majority equity interest in Baker Street Advisors LLC (“Baker Street”). After the closing of the transaction, the management partners of Baker Street will continue to hold a substantial portion of the equity of the business and direct its day-to-day operations.
Sign-up for AMG Wealth Partners Announces Investment in Baker Street Advisors investment picks
2014/12/11
First Presentation of Phase 3 Data From Brodalumab Psoriasis Program THOUSAND OAKS, Calif.
Sign-up for Amgen And AstraZeneca To Present Results From Phase 3 AMAGINE-1™ Study Evaluating Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis investment picks
2015/1/5
Alliance Combines Amgen's Oncology Targets and Kite's Leading CAR T Cell Therapy Platform to Develop new Therapeutic Candidates Kite to Receive a $60 Million Upfront Payment From Amgen and Eligible for up to $525 Million in Regulatory and Sales Milestone Payments per Amgen Program; Plus, Tiered High Single- to Double-Digit Royalties for Sales and License of Kite's Intellectual Property for CAR T Cell Products Amgen Eligible to Receive up to $525 Million in Milestone Payments per Kite Program; Plus, Tiered Single-Digit Sales Royalties Kite to Host Conference Call Today at 4:00 PM Eastern Time THOUSAND OAKS, Calif.
Sign-up for Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies investment picks
2015/1/5
By Tess Stynes Amgen Inc. and Kite Pharma Inc. reached a research collaboration and license agreement to develop cancer immunotherapy treatments that focus on Amgen's array of cancer targets and Kite Pharma's autologous cell therapy platform.
Sign-up for Amgen and Kite Pharma in cancer immunotherapy pact investment picks
2015/1/12
MD Anderson's Moon Shots Program key to Collaboration THOUSAND OAKS, Calif.
Sign-up for Amgen and MD Anderson Announce Agreement to Develop BiTE® Therapies for Myelodysplastic Syndrome investment picks
2014/12/6
Data From Pivotal Trial Published in the New England Journal of Medicine and Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition Overall Response Rate, Duration of Response, Health-Related Quality of Life Secondary Endpoints Met; Overall Survival Continues to be Monitored Results to be Presented During an Oral Session at ASH on Sunday, December 7 at 12 p.m. PT Data to be Featured in ASH Press Briefing on Saturday, December 6 at 8 a.m. PT THOUSAND OAKS, Calif.
Sign-up for Amgen And Onyx Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma investment picks
2014/12/17
THOUSAND OAKS, Calif.
Sign-up for Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend investment picks
2015/3/2
Neulasta Delivery Kit Provides Administration Option for Patients who may not Otherwise Need to Return to Clinic or Hospital the day After Chemotherapy THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Launch Of New Neulasta® (Pegfilgrastim) Delivery Kit investment picks
2014/12/6
78 Percent of Patients Treated With BLINCYTO Experienced a Complete Minimal Residual Disease (MRD) Response After One Treatment Cycle Results to be Presented During an Oral Session at the American Society of Hematology (ASH) 56th Annual Meeting and Exposition on Monday, December 8 at 10:30 a.m. PT Data to be Featured in ASH Press Briefing on Saturday, December 6 at 10 a.m. PT THOUSAND OAKS, Calif.
Sign-up for Amgen Announces New Data From Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease investment picks
2015/2/25
Third Phase 3 Study Met Non-Inferiority and Superiority Endpoints in the Reduction of Parathyroid Hormone THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Positive Results From Head-To-Head Study Comparing The Efficacy And Safety Of AMG 416 With Cinacalcet In Patients With Secondary Hyperparathyroidism Receiving Hemodialysis investment picks
2015/2/3
Primary Efficacy Analysis Demonstrates Clinical Equivalence Second Positive Phase 3 Study for Amgen's ABP 501 THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ABP 501 Compared With Adalimumab In Patients With Moderate-To-Severe Rheumatoid Arthritis investment picks
2015/1/22
THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results investment picks
2014/12/22
Sponsorship Secures Resources Needed for Biotech Startups to Advance Innovative Research CAMBRIDGE, Mass.
Sign-up for Amgen Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: AmerisourceBergen to Acquire MWI Veterinary Supply, the Leading Animal Health Distribution Company in the United States to Amgen Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent